APA (7th ed.) Citation

McAllister, M., Mistry, N., Pepin, X., Cole, S., Tannergren, C., Stamatopoulos, K., . . . Popkin, M. (2026). Physiologically Based Biopharmaceutics Modelling—Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary Report. Pharmaceutics, 18(5), 566. https://doi.org/10.3390/pharmaceutics18050566

Chicago Style (17th ed.) Citation

McAllister, Mark, et al. "Physiologically Based Biopharmaceutics Modelling—Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary Report." Pharmaceutics 18, no. 5 (2026): 566. https://doi.org/10.3390/pharmaceutics18050566.

MLA (9th ed.) Citation

McAllister, Mark, et al. "Physiologically Based Biopharmaceutics Modelling—Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary Report." Pharmaceutics, vol. 18, no. 5, 2026, p. 566, https://doi.org/10.3390/pharmaceutics18050566.